SEC Form 4 · accession 0001159036-15-000084
HALOZYME THERAPEUTICS, INC. · HALO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth J Kelley
Director
Period of report
Aug 28, 2015
Accepted (ET)
Sep 1, 2015 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 28, 2015 | M | 10,000 | $10.37 | A | 208,051 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $10.37 | Aug 28, 2015 | M | 10,000 | D | May 15, 2008 | May 15, 2017 | Common Stock | 10,000 | 0 | D |